The mechanisms by which chronic inflammatory lung diseases, particularly chronic obstructive pulmonary disease, confer enhanced risk for lung cancer are not welldefined. To investigate whether nuclear factor (NF)-jB, a key mediator of immune and inflammatory responses, provides an interface between persistent lung inflammation and carcinogenesis, we utilized tetracycline-inducible transgenic mice expressing constitutively active IjB kinase b in airway epithelium (IKTA (IKKb transactivated) mice). Intraperitoneal injection of ethyl carbamate (urethane), or 3-methylcholanthrene (MCA) and butylated hydroxytoluene (BHT) was used to induce lung tumorigenesis. Doxycycline-treated IKTA mice developed chronic airway inflammation and markedly increased numbers of lung tumors in response to urethane, even when transgene expression (and therefore epithelial NF-jB activation) was begun after exposure to carcinogen. Studies using a separate tumor initiator/promoter model (MCA þ BHT) indicated that NF-jB functions as an independent tumor promoter. Enhanced tumor formation in IKTA mice was preceded by increased proliferation and reduced apoptosis of alveolar epithelium, resulting in increased formation of premalignant lesions. Investigation of inflammatory cells in lungs of IKTA mice revealed a substantial increase in macrophages and lymphocytes, including functional CD4 þ /CD25 þ /FoxP3 þ regulatory T lymphocytes (Tregs). Importantly, Treg depletion using repetitive injections of anti-CD25 antibodies limited excessive tumor formation in IKTA mice. At 6 weeks following urethane injection, antibody-mediated Treg depletion in IKTA mice reduced the number of premalignant lesions in the lungs in association with an increase in CD8 lymphocytes. Thus, persistent NF-jB signaling in airway epithelium facilitates carcinogenesis by sculpting the immune/inflammatory environment in the lungs.
The mechanisms by which chronic inflammatory lung diseases, particularly chronic obstructive pulmonary disease, confer enhanced risk for lung cancer are not welldefined. To investigate whether nuclear factor (NF)-jB, a key mediator of immune and inflammatory responses, provides an interface between persistent lung inflammation and carcinogenesis, we utilized tetracycline-inducible transgenic mice expressing constitutively active IjB kinase b in airway epithelium (IKTA (IKKb transactivated) mice). Intraperitoneal injection of ethyl carbamate (urethane), or 3-methylcholanthrene (MCA) and butylated hydroxytoluene (BHT) was used to induce lung tumorigenesis. Doxycycline-treated IKTA mice developed chronic airway inflammation and markedly increased numbers of lung tumors in response to urethane, even when transgene expression (and therefore epithelial NF-jB activation) was begun after exposure to carcinogen. Studies using a separate tumor initiator/promoter model (MCA þ BHT) indicated that NF-jB functions as an independent tumor promoter. Enhanced tumor formation in IKTA mice was preceded by increased proliferation and reduced apoptosis of alveolar epithelium, resulting in increased formation of premalignant lesions. Investigation of inflammatory cells in lungs of IKTA mice revealed a substantial increase in macrophages and lymphocytes, including functional CD4 þ /CD25 þ /FoxP3 þ regulatory T lymphocytes (Tregs). Importantly, Treg depletion using repetitive injections of anti-CD25 antibodies limited excessive tumor formation in IKTA mice. At 6 weeks following urethane injection, antibody-mediated Treg depletion in IKTA mice reduced the number of premalig-
Introduction
Lung cancer is epidemic in the United States and worldwide, largely related to cigarette smoking (Miller, 2005; Parkin et al., 2005; Siegel et al., 2011) . Among smokers, the primary risk factor for developing lung cancer is the presence of chronic obstructive pulmonary disease (COPD), (Young et al., 2009) which is characterized by chronic pulmonary inflammation, airway remodeling and destruction of lung parenchyma (Rabe et al., 2007; Barnes and Celli, 2009; Thiberville et al., 2009) . Several studies have confirmed that COPD is an independent risk factor for lung cancer (Skillrud et al., 1986; Tockman et al., 1987) . We and others have proposed that chronic inflammation, as occurs in COPD, could provide the mechanistic link to explain increased lung cancer risk in these patients (Stathopoulos et al., 2007; Houghton et al., 2008; Moghaddam et al., 2009 ). However, the specific inflammatory cells and pathways involved in potentiating lung cancer risk are not well-defined.
The nuclear factor (NF)-kB signaling pathway, an elegant system that executes transcriptional responses to cell stress, regulates expression of cytokines, chemokines, adhesion molecules, apoptosis-regulating genes, matrix metalloproteinases, enzymes and receptors (Blackwell and Christman, 1997; Smale, 2010) . NF-kB is activated by a number of tumor-promoting agents, and is involved in production of proteins that enhance cell survival and proliferation (Pahl, 1999; Pasparakis, 2009 ). In humans, NF-kB has been reported to be activated in precancerous lesions and lung cancer specimens obtained by resection or biopsy (Tang et al., 2006) . We and others have shown that the NF-kB pathway impacts lung tumor development in mice by enhancing epithelial cell survival in both chemical carcinogens and genetic models (Stathopoulos et al., 2007; Meylan et al., 2009; Takahashi et al., 2010) .
Despite recent interest in the role of NF-kB in lung cancer, a number of key questions remain.
In these studies, we asked whether NF-kB provides a mechanistic link between chronic airway inflammation and increased risk of lung carcinogenesis, and if so, how persistent NF-kB activation augments tumor formation. To regulate NF-kB in the lungs, we utilized transgenic mice with inducible expression of active IkB kinase b (IKKb) in airway epithelial cells (IKTA (IKKb transactivated) mice) . We found that long-term activation of NF-kB resulted in persistent airway inflammation characterized by macrophage and lymphocyte infiltration. Following exposure to chemical carcinogens, IKTA mice exhibited enhanced lung tumorigenesis even when lung inflammation was induced after carcinogen exposure. Increased tumor formation in IKTA mice was preceded by increased proliferation of airway epithelial cells and enhanced formation of premalignant lesions. Further investigation of the nature of the lung-inflammatory cell influx of IKTA mice revealed a substantial increase in regulatory T lymphocytes (Tregs). Depletion of these cells resulted in increased numbers of CD8 lymphocytes in the lungs, and a reduction of lung tumor formation in IKTA mice. Collectively, our findings show that chronic NF-kBdriven inflammation enhances lung tumor formation in a paracrine manner by regulation of key immune cell populations that impact epithelial cell proliferation and survival.
Results
Chronic NF-kB-driven airway inflammation enhances urethane-induced lung carcinogenesis IKTA mice express constitutively active IKKb in Clara cell-specific protein (CCSP)-expressing airway epithelium after doxycycline (dox) treatment . Addition of 0.5 mg/ml of dox to drinking water resulted in an early neutrophil-predominant inflammatory cell influx during the first 2 weeks followed by a shift in the inflammatory cell profile to a predominance of macrophages and lymphocytes by week 4 of continuous dox, as identified in bronchoalveolar lavage (BAL) (Figure 1a ). This chronic inflammatory profile persisted for at least 4 months of dox treatment. As indicated in Figure 1b , this shift in inflammatory pattern occurred despite consistent levels of transgene expression in IKTA mice. Although some mice (o25%) succumbed to acute lung inflammation during the first 2 weeks of dox treatment, after this period mice appeared healthy and active without weight loss or appearance of chronic illness.
We next investigated whether chronic airway inflammation induced by NF-kB activation increases susceptibility to urethane-induced lung tumor formation. We treated mice with a single intraperitoneal injection of urethane and induced transgene expression by treatment with dox during three different time intervals ( Figure 2a ): (1) beginning 2 weeks before urethane and continuing for 3 weeks after urethane injection (weeks À2 to 3), (2) beginning at week 4 after urethane injection and continuing until harvest at 16 weeks (weeks 4 to 16), and (3) beginning 2 weeks before urethane injection and continuing through weeks 16 after urethane injection (weeks À2 to 16). Prior studies on tet-on models have shown that withdrawal of dox results in loss of transgene expression by 7 days (Perl et al., 2002) . Wild-type (WT) mice treated with a similar dox regimen to IKTA mice were used as controls in each experiment. Lung tumor formation was assessed in all studies at 16 weeks after urethane injection. In the first experiment, IKTA mice treated with dox during weeks À2 to 3 (tumor initiation and early promotion phase) showed increased tumor formation compared with WT mice with or without dox treatment (Figure 2b ). In the second experiment, IKTA mice treated with dox between weeks 4-16 after urethane treatment (late promotion and progression phase) developed significantly more tumors than WT controls (Figure 2c ). In the third experiment, IKTA mice treated with dox for the duration of the experiment (weeks À2 to 16) showed a similar increase in tumor numbers to that seen with the weeks 4-16 regimen (Figure 2d ). Together, these studies show that epithelial NF-kB activation enhances tumor formation in the lungs. Compared with IKTA mice that were Epithelial NF-jB and Tregs in lung tumorigenesis R Zaynagetdinov et al treated with dox during weeks À2 to 3, greater tumor numbers were identified in IKTA mice treated with dox during later periods.
Additional urethane-treated WT and IKTA mice were given dox throughout the experimental period (weeks À2 to 16) to confirm the increase in lung tumors by histological examination. Similar to surface tumors, tumor numbers were increased on lung sections from IKTA mice compared with WT controls (Figure 3a ). Lung tumors appeared as solid or papillary adenomas without features of adenocarcinoma. Morphometric analysis indicated that the mean tumor diameters were similar between groups (Figure 3b ). We also evaluated the airway inflammation in tumor-containing mice by performing BAL at the time of harvest. Urethanetreated IKTA mice showed increased BAL macrophages and lymphocytes compared with WT controls (Figure 3c ), similar to the pattern of chronic inflammation observed in prior experiments in which IKTA mice were treated with dox alone (Figure 1a ).
We measured cellular proliferation by 5-bromodeoxyuridine (BrdU) staining in lung tumors from WT and IKTA mice treated with urethane and dox from weeks À2 to 16. The percentage of BrdU-positive cells in tumors from WT mice was 1.7±0.4 compared with 1.9 ± 0.6 in tumors from IKTA mice ( Figure 3d ). This finding, together with the similarities in tumor size and appearance, indicate that chronic NF-kB activation in our model does not substantially influence growth and progression of established tumors. Instead, these results support the idea that epithelial NF-kB activation affects the promotion phase of tumorigenesis.
NF-kB can function as the sole tumor promoter and increases tumor formation irrespective of genetic background Although urethane is a complete carcinogen, most carcinogens require a separate promoter agent to achieve tumor formation. 3-methylcholanthrene (MCA), a component of tobacco smoke, is a weak carcinogen that requires the addition of a separate promoter agent such as butylated hydroxytoluene (BHT) to reproducibly generate tumors in mice (Malkinson et al., 1997) . Prior studies have shown that BHT promotes lung tumors only in strains in which it also induces lung inflammation (Malkinson et al., 2000; Bauer et al., 2005) . We asked whether MCA or BHT induces NF-kB activation in the lungs, using NF-kB reporter mice (HLL; FVB background) that express luciferase under the control of an NF-kB-dependent promoter (Yull et al., 2003; Stathopoulos et al., 2007) . Mice were treated with a single i.p. injection of MCA or BHT. As shown in Figure 4a , MCA failed to induce NF-kB activity in HLL mice, but BHT treatment resulted in significantly increased bioluminescence over the chest 7 days after injection. We then asked whether NF-kB activation could substitute for BHT treatment to Figure 2 NF-kB activation in IKTA transgenic mice enhances lung tumorigenesis after urethane injection. (a) Timeline for treatment of mice with a single i.p. injection of carcinogen (urethane, 1 g/kg) and dox during three different time intervals. (b) WT and IKTA mice were treated with dox for 2 weeks before urethane and continued for another 3 weeks (weeks À2 to 3). WT mice without dox were used as an additional control (n ¼ 9-11 per group, *Po0.01 compared with the other groups). (c) WT and IKTA mice were treated with dox beginning at 4 weeks after urethane and continued until the time of harvest (weeks 4-16) (n ¼ 14 for WT and n ¼ 7 for IKTA, *Po0.01 compared with WT). (d) WT and IKTA mice treated with dox beginning 2 weeks before urethane and continuing for the duration of the experiment (weeks À2 to 16). A group of IKTA mice without dox treatment (IKTA) was included (n ¼ 7-9 per group, *Po0.01 compared with the other groups).
Epithelial NF-jB and Tregs in lung tumorigenesis R Zaynagetdinov et al promote tumor formation after exposure to MCA. WT or IKTA mice were treated with a single i.p. dose of MCA and 8 weekly i.p. injections of BHT, or vehicle (corn oil) with or without continuous dox beginning 2 weeks before MCA treatment. In contrast to WT mice, MCA alone was efficient at generating lung tumors in dox-treated IKTA mice at 16 weeks after MCA injection. The combination of dox treatment and BHT resulted in an even greater tumor burden after MCA injection in IKTA mice ( Figure 4b ). Histological counting of tumors on lung sections confirmed these differences between groups and, similar to the urethane model, no differences in tumor size or appearance were noted (data not shown). Together, these studies show that NF-kB activation can substitute for the tumorpromoting effect of BHT in this model. We next wondered whether NF-kB activation could increase urethane-induced lung tumor formation in the tumor-resistant C57BL/6 strain. In these studies, WT and IKTA mice (both on C57BL/6 background) were treated with dox followed by a single dose of urethane, and dox was continued until the time of harvest at 6 months. Although lung-surface tumor counts were lower in C57BL/6 mice compared with FVB mice, IKTA C57BL/6 mice showed an approximately 2.5-fold increase in lung tumors compared with WT C57BL/6 mice ( Figure 4c ). Therefore, whereas NF-kB activation did not overcome the strain-related differences in tumor susceptibility, the relative increase in lung-surface tumors was similar between IKTA mice on FVB or C57BL/6 backgrounds. These findings support the idea that genetic susceptibility to tumor formation following exposure to a carcinogen can be modified by the presence of an inflammatory lung environment.
NF-kB activation supports development of premalignant lesions in the lungs and augments epithelial cell proliferation and survival
As our data indicated that NF-kB activation in airway epithelial cells promotes lung tumor formation, we investigated whether IKTA mice (FVB) developed increased numbers of premalignant atypical adenomatous hyperplasia (AAH) lesions. We performed a timecourse study in which IKTA and WT mice (both treated with dox beginning 2 weeks before urethane treatment) were harvested at 3, 6 and 9 weeks after urethane treatment. Analysis of lung sections revealed that IKTA mice had significantly more AAH lesions than WT controls at 6 and 9 weeks after urethane treatment (Figures 5a and b ). We identified no differences in size or vascularity of AAH lesions between WT and IKTA mice at 6 weeks after urethane treatment. VEGF levels in BAL were similar between the two groups (49 ± 9 pg/ ml in WT mice and 50 ± 10 pg/ml in IKTA mice).
In addition, we measured cell proliferation and apoptosis in the lungs of dox-treated IKTA and WT mice after urethane treatment. By proliferating cell nuclear antigen (PCNA) staining, we found a marked increase in proliferation of cells in the lung parenchyma (mostly type II alveolar epithelial cells) from IKTA mice at 6 weeks after urethane injection (Figures 5c and d) , Epithelial NF-jB and Tregs in lung tumorigenesis R Zaynagetdinov et al correlating with the increase in AAH lesions identified in these mice. Interestingly, by 9 weeks PCNA staining returned to near-baseline in IKTA and WT mice, indicating that cellular proliferation increased transiently after urethane treatment. In contrast, active caspase-3 staining of these sections obtained 9 weeks after urethane treatment revealed reduced numbers of apoptotic cells in the lungs of IKTA mice compared with controls (Figure 5e ). At 3 and 6 weeks after urethane treatment, very few active caspase-3-positive cells were identified in either WT or IKTA mouse lungs. Together, these findings indicate that chronic NF-kBdependent inflammation creates a pro-tumorigenic environment that supports the expansion of initiated epithelial cells into premalignant AAH lesions during the first few weeks after urethane treatment, and supports the persistence of these lesions by reduced apoptosis at later time points.
Tregs enhance tumor formation in the setting of chronic airway inflammation Although transgene expression in IKTA mice is localized to airway epithelium , we observed increased numbers of AAH lesions and increased proliferation of cells in lung parenchyma after urethane treatment. Therefore, we reasoned that inflammatory cells attracted by mediators produced by airway epithelia, rather than cell-autonomous effects of increased NF-kB activation, might mediate the pro-tumorigenic phenotype of IKTA mice. We investigated the lymphocyte influx identified in IKTA mice as these cells are increased in the airways of patients with COPD and can influence tumor biology in a variety of ways (Colombo and Piconese, 2007; Lee et al., 2007; Smyth et al., 2007; Plumb et al., 2009; Lane et al., 2010; Mougiakakos et al., 2010; Wilke et al., 2010) . We evaluated lymphocyte subsets in the lungs of IKTA mice after dox treatment. The total number of CD4 þ and CD8 þ lymphocytes was increased after dox treatment (data not shown); however, because of the large macrophage influx, CD8 þ lymphocytes were reduced as a percentage of total CD45 þ leukocytes. In contrast, the proportion of CD4 þ T cells was relatively unchanged up to 6 weeks of dox treatment related to a large influx of CD4 þ CD25 þ Foxp3 þ Tregs (Figures 6a and b) . By 1 week after initiation of dox treatment, almost 40% of CD4 þ lymphocytes were Tregs, and this increase persisted up to 6 weeks after initiation of dox treatment. By real-time RT-PCR (reverse transcriptase-PCR), we evaluated the production of NF-kB-regulated chemokines that could facilitate Treg recruitment. As shown in Figure 6c , we identified increased mRNA expression of C-C motif chemokine ligands (CCL) 17, 20 and 22 in lung homogenates of IKTA mice after 6 weeks of dox treatment compared with dox-treated WT controls.
To test whether CD4 þ CD25 þ Foxp3 þ Tregs isolated from lungs of dox-treated IKTA mice possessed regulatory properties, we assessed their ability to suppress effector T (Teff) cell proliferation in an allogeneic mixed lymphocyte reaction (MLR) assay Banerjee et al., 2006) . For these studies, CD4 þ CD25 þ cells were isolated from lungs of dox-treated IKTA (FVB) mice. Approximately 93% of these cells were also positive for Foxp3 (data not shown). Teff cells from spleens of naive FVB mice were activated by allogeneic mature dendritic cells (DCs), and the suppressive effect of CD4 þ CD25 þ T cells on proliferation of Teff cells was evaluated by measuring carboxyfluorescein succinimidyl ester (CFSE) fluorescence. CD4 þ CD25 þ T cells from IKTA mice inhibited the proliferation of Teff cells with the most effective suppression observed at Treg:Teff cell ratios ranging from 1:1 to 1:4 ( Figure 7a ). These results demonstrate that CD4 þ CD25 þ Foxp3 þ T cells isolated from lungs of IKTA mice have immunosuppressive properties characteristic of Tregs.
As Tregs have been implicated in altered immune surveillance and evasion of malignant cells from immune-mediated destruction, we depleted Tregs using a monoclonal antibody approach to investigate the impact of Tregs on the increased tumorigenesis observed in urethane-treated IKTA mice. We established that Figure 5 Increased number of AAH lesions in lungs of IKTA mice is associated with increased proliferation of cells in lung parenchyma. (a) WT and IKTA mice were treated with dox beginning 2 weeks before urethane treatment and continuing until the time of harvest at 3, 6 or 9 weeks after urethane treatment. AAH lesions were counted on H&E-stained lung sections (n ¼ 6-12 per group, *Po0.05 compared with WT mice at the same time point). (b) Illustration of characteristic AAH lesions in WT and IKTA mice. (c) PCNA scoring was done on H&E-stained lung sections. (n ¼ 6-12 per group, *Po0.05 compared with WT at the same time point). (d) Immunohistochemistry for PCNA showing nuclear staining (brown) predominantly in type II alveolar epithelial cells throughout lung parenchyma (original magnification Â 400). (e) Active caspase-3 scoring on lung sections from dox-treated WT and IKTA mice treated continuously with dox, and harvested at 9 weeks after urethane treatment (n ¼ 8 for IKTA and n ¼ 10 for WT, *Po0.05). Semi-quantitative scoring of PCNA or active caspase-3 staining was performed on ten sequential, nonoverlapping tissue fields of lung parenchyma evaluated under Â 400 magnification. Each tissue field was scored using a 0-4 point system (0-no positive cells; 1-45% positive cells; 2-5-10% positive cells; 3-10-25% positive cells; 4->25% positive cells).
Epithelial NF-jB and Tregs in lung tumorigenesis R Zaynagetdinov et al monoclonal anti-CD25 antibodies were able to substantially reduce the CD4 þ CD25 þ lymphocyte population (Figure 7b ). To test the contribution of Tregs in lung carcinogenesis, we treated our mice with anti-CD25 or isotype control antibodies for 4 months. As indicated in Figure 7c , Treg depletion did not influence tumorigenesis in WT mice, but significantly blocked the increased tumor formation observed in IKTA mice. No differences in tumor size or appearance were identified. Next, we investigated whether the influx of Tregs observed in IKTA mice promotes lung tumorigenesis by impacting the early stages of tumor development. We treated IKTA mice with anti-CD25 or control antibodies as described above, and analyzed lungs for the appearance of AAH lesions at 6 weeks after injection of urethane. We observed reduced numbers of AAH lesions after depletion of CD25 þ cells (Figure 8a ). In addition, flow cytometry analysis of lungs from these mice confirmed a reduction in Tregs but revealed an increased infiltration with CD8 þ lymphocytes (Figures 8b-d) .
We wondered whether depletion of Tregs in IKTA mice could alter Th1/Th2 polarization of lung lymphocytes. Therefore, we isolated T cells from lungs of doxtreated WT controls or IKTA mice at 1 week after the injection with anti-CD25 or control antibodies and investigated production of IFNg and IL-4 in response to stimulation with phorbol myristate acetate (PMA)/ ionomycin. Although we found no differences in the percentage of IKTA lymphocytes producing IFNg or IL-4 after Treg depletion, the proportion of IFNgproducing lymphocytes was lower in IKTA lymphocytes compared with controls (Figures 8e and f) . We next Figure 6 NF-kB activation in IKTA transgenic mice increases the number of CD4 þ CD25 þ Foxp3 þ regulatory T cells in the lungs. (a) Representative flow cytometry plots for identification of CD4 þ T cells, CD8 þ T cells and CD4 þ CD25 þ Foxp3 Tregs in lungs of WT and IKTA mice treated with doxycycline (dox) for 3 weeks. (b) Total CD4 þ T cells, CD8 þ T cells and CD4 þ CD25 þ Foxp3 Tregs identified by flow cytometry in lungs from untreated WT mice and IKTA mice, 1-6 weeks after initiation of dox treatment (n ¼ 4 per group for each time interval, *Po0.01). (c) Relative mRNA expression of CCL17, CCL20 and CCL22 in lung homogenates prepared from WT and IKTA mice after 6 weeks of dox treatment (n ¼ 7 for IKTA and n ¼ 10 for WT, *Po0.01).
Epithelial NF-jB and Tregs in lung tumorigenesis R Zaynagetdinov et al asked whether Tregs could enhance lung tumorigenesis through downregulation of cytotoxic T lymphocyte responses. To test whether CD8 þ lymphocytes could have a role in suppressing tumor formation in IKTA mice, we depleted CD8 lymphocytes using anti-CD8 antibodies. Flow cytometry analysis of lung cells confirmed efficient depletion of these cells (Figure 9a ). As indicated in Figure 9b , continuous depletion of CD8 lymphocytes in IKTA mice increased the number of lung tumors at 4 months after injection of urethane. Together, these studies suggest that Tregs recruited to the lungs could facilitate urethane-induced tumorigenesis through suppression of cytotoxic CD8 lymphocytes.
Discussion
The NF-kB pathway is increasingly recognized as an important player in lung cancer development and progression. Previously, we showed that inhibition of NF-kB signaling reduces lung tumor formation induced by chemical carcinogens (Stathopoulos et al., 2007) , a finding that has been since corroborated and expanded by others in genetic models of lung cancer resulting from oncogenic Kras expression (Meylan et al., 2009; Basseres et al., 2010; Takahashi et al., 2010) . Here, we demonstrate that chronic activation of the NF-kB pathway amplifies tumor formation and can function as the sole tumor promoter in the presence of an initiator (mutagen). The crucial time interval for these effects appears to be the promotion phase of tumorigenesis, leading to increased epithelial cell proliferation and increased premalignant AAH lesions by 6 weeks after urethane injection. A reduction in epithelial apoptosis at later time points may also contribute to increased tumorigenesis in the setting of chronic NF-kB-induced inflammation. We found that Tregs are recruited to the lungs in IKTA mice, and that depletion of Tregs reduced tumorigenesis in IKTA mice but not in WT mice. This finding implicates Tregs as being important for the excessive tumor formation resulting from chronic airway inflammation. Although the role of Tregs in COPD and other chronic airway diseases is not well-defined, increased Tregs have been reported in lungs of COPD patients when compared with nonsmokers in several studies (Lee et al., 2007; Smyth et al., 2007; Plumb et al., 2009; Lane et al., 2010) , indicating that our findings may have relevance to the increased tumor risk associated with chronic inflammatory diseases of the lungs. Accumulating evidence supports the idea that cross talk between epithelial and immune cells in the tumor microenvironment sets up a cycle of communication with pro-tumorigenic effects. Here, we focused on the (c) Surface tumors per left lung from mice treated with anti-CD25 antibodies (CD25) or isotype control antibodies (IgG) the day before urethane treatment and on day 6, followed by repeated i.p. injections every 2 weeks for 4 months (n ¼ 5-7 per group, *Pp0.05 for IKTA mice treated with anti-CD25 Ab compared with IKTA mice treated with isotype control Ab).
Epithelial NF-jB and Tregs in lung tumorigenesis ability of epithelial NF-kB pathway activation to modify the microenvironment in a pro-tumorigenic manner through recruitment and activation of im-mune/inflammatory cells. Because of the substantial increase in Tregs observed in our mouse model and published reports of elevated numbers of these cells in lungs of patients with COPD, (Smyth et al., 2007) we investigated the role of Tregs in exaggerated tumorigenesis in IKTA mice. For many tumor types, there is a clear connection between abundant accumulation of Tregs in established tumors and poor clinical outcome (Colombo and Piconese, 2007; Mougiakakos et al., 2010; Wilke et al., 2010; Schneider et al., 2011) ; however, there is little known regarding the role of Tregs in tumor promotion. A prior study showed that rapamycin treatment reduced lung tumor formation in A/J mice treated with N-nitrosamine (4-(methylnitrosamino)-1-1(3-Pyridyl)-butanone), in association with decreased numbers of Foxp3 þ cells in the lungs (Granville et al., 2009 ). In addition, crossing Scurfy mice, which bear a loss-of-function mutation in the (e,f) Percentages of CD4 þ Foxp3-IL-4 þ and CD4 þ Foxp3-IFNg þ lymphocytes isolated from lungs of dox-treated IKTA mice at 1 week after a single i.p. dose of 500 mg of anti-CD25 (PC61) or isotype control antibodies. Cells were restimulated with PMA/ionomycin for 6 h in vitro and analyzed by flow cytometry. We found that functional Tregs were recruited to the lungs in an NF-kB-dependent manner in IKTA mice. To investigate the role of Tregs in lung tumorigenesis, we exploited well-known approach of cell depletion using anti-CD25 monoclonal antibody. These antibodies have been widely used for isolation of Tregs, as well as for elimination of Tregs in vivo. However, conflicting evidence has been reported regarding the nature of the inhibitory effects of anti-CD25 monoclonal antibody treatment on the Tregs population. Kohm et al. showed that treatment with CD25 antibody (clone 7D4) resulted in functional inactivation rather than depletion of Tregs (Kohm et al., 2006) . Other groups have demonstrated depletion of Tregs after injection of anti-CD25 antibodies using clone PC61, as was used in our studies (Stephens and Anderton, 2006; Zelenay and Demengeot, 2006; Setiady et al., 2010) . By reducing the number of Tregs in our model, we found that these cells contribute to the increased tumor formation in IKTA mice. Interestingly, depletion of Tregs had no effect on tumor formation in urethane-treated WT mice, suggesting that Tregs can enhance tumor promotion, but are not necessary for urethane-induced tumorigenesis. Therefore, recruitment of Tregs may be one important mechanism by which chronic airway inflammation facilitates tumor development. Tregs may facilitate cancer cell evasion from immune-mediated destruction through a variety of mechanisms, including elaboration of an immunosuppressive cytokine profile, as well as impaired production or function of tumor-specific T cells (Curiel et al., 2004; Nummer et al., 2007) . Our findings suggested that the impact of Tregs on lung tumorigenesis in IKTA mice is unlikely to be explained by phenotypic alterations of effector-CD4 lymphocytes. Rather, based on the increased influx of CD8 lymphocytes observed after CD25 depletion in IKTA mice, we speculate that suppression of cytotoxic CD8 lymphocyte responses contributes to the pro-tumorigenic effects of Tregs in our model.
Whereas the absolute number of lung tumors induced by urethane was lower in the tumor-resistant C57BL/6 background compared with the more susceptible FVB strain, NF-kB activation resulted in proportionally similar increase in tumorigenesis in both strains of IKTA mice compared with strain-specific controls. Thus, NF-kB-induced chronic inflammation does not appear to completely overcome genetic resistance to lung tumorigenesis. This observation is in accordance with observations in humans; only one fifth of heavy smokers develop lung cancer (Brody and Spira, 2006; Barnes, 2008) . Although the explanation for individual differences in susceptibility to carcinogenic exposure is a focus of intense research, it is likely that environmental influences, like chronic airway inflammation, can alter the underlying genetic risk (Alberg et al., 2007; Chung and Adcock, 2008) . Therefore, interventions to modulate inflammatory pathways or mediators could be effective for cancer chemoprevention regardless of genetic susceptibility.
An association between chronic inflammation and cancer has been recognized in many human organ systems, including the lungs (Schottenfeld and Beebe-Dimmer, 2006) . In addition to patients with COPD, chronic airway inflammation occurs in a large number of current and ex-smokers without airway obstruction (Willemse et al., 2005; Lapperre et al., 2006; Gamble et al., 2007) . Also, environmental exposure to air pollutants, such as diesel exhaust particulates, has been shown to cause or exacerbate airway inflammation and induce NF-kB activation in bronchial epithelial cells (Bonvallot et al., 2001; McCreanor et al., 2007) . Therefore, the influence of NF-kB and chronic inflammation on tumorigenesis in the lungs may be broadly important in promoting lung cancer. However, more work is needed to determine the impact of NF-kB signaling on lung carcinogenesis in humans. The NF-kB pathway or components of the chronic inflammatory environment in the lungs, like Tregs, might serve as important targets for cancer chemoprevention strategies.
Materials and methods
Animal models IKTA mice selectively expressing a constitutively active form of human IKKb in airway epithelium have been reported previously . We used sex-matched IKTA mice and WT littermate controls (weighing 20-25 g) on the original FVB background, as well as transgenic mice backcrossed >9 generations into the C57BL/6 background. To activate transgene expression, mice were provided ad lib with 0.5 mg/ml dox in drinking water. To induce tumors, urethane was given by a single i.p. injection (1 g/kg). In other studies, 15 mg/g MCA was given by a single i.p. injection and 200 mg/g BHT or vehicle (corn oil) was delivered by 8 weekly i.p. injections. NF-kB reporter transgenic HLL mice on FVB background have been used for bioluminescence imaging, as previously reported (Yull et al., 2003; Stathopoulos et al., 2007) . All mouse experiments were approved by the Vanderbilt University Institutional Animal Care and Utilization Committee.
In vivo depletion of Tregs and CD8 lymphocytes CD25 þ Treg cells were depleted using modifications of previously published protocols (Degl'Innocenti et al., 2008) . For depletion, 500 mg monoclonal anti-CD25 antibody (clone PC61; ATCC (American Type Culture Collection, Manassas, VA, USA)) or control IgG (Jackson ImmunoResearch, West Grove, PA, USA) were injected i.p. into WT or IKTA mice at day À1 (before injection of urethane), day 6 and every 2 weeks for 16 weeks. CD8 cells were depleted with i.p. injection of 400 mg of 2.43 (anti-CD8) antibodies on day À1. Thereafter, maintenance injections of 200 mg antibody were given weekly, as described (Hashimoto et al., 2005) . The efficacy of the depletion was determined by FACS analysis of single cell suspension from lungs of dox-treated IKTA mice.
BAL collection and cell counts BAL was performed with three aliquots of 800 ml sterile normal saline. Fluid was combined and centrifuged at 400 g for 10 min to separate cells from supernatant. Total and differential cell counts were done, as previously described (Stathopoulos et al., 2007) .
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Flow cytometry
Lungs were digested in RPMI medium containing collagenase XI (0.7 mg/ml; Sigma-Aldrich) and type IV bovine pancreatic DNase (30 mg/ml; Sigma-Aldrich). After elimination of red blood cells using red blood cell lysis buffer (BioLegend, San Diego, CA, USA), cells were stained with antibodies: CD4-FITC (RM4-5), CD25-APC (PC61.5), FoxP3-PE (FJK-16s) from e-Bioscience, San Diego, CA, USA CD45-Pacific Blue (30-F11, Invitrogen, Carlsbad, CA, USA), CD3-V500 (500A2), CD8-Alexa Fluor 700 (53-6.7), IFNg-PE-Cy7 (XMG1.2) and IL-4-PE (11B11) from BD Biosciences, San Jose, CA, USA. For determining Th1/Th2 polarization, T cells were isolated from lungs of dox-treated IKTA mice using T-cell enrichment columns (R&D, Minneapolis, MN, USA), and re-stimulated with PMA (1 ng/ml) and ionomycin (1 mM) for 6 h in the presence of Golgi-stop (BD Biosciences) at 37 1C, 5% CO 2 After staining with CD3 and CD4 antibodies, cells were permeabilized and processed for intracellular staining using anti-IFNg, IL-4 and FoxP3 antibodies. Cells were analyzed using a LSR II flow cytometer (BD Biosciences), and data were analyzed using Flow Jo 7.2 software (Tree Star Inc., Ashland, OR, USA).
Lung tumor enumeration
Surface tumors were counted under a dissecting microscope by two readers blinded to the samples and averaged, as previously described (Stathopoulos et al., 2007) . Tumor diameter was determined using digital calipers (Fisher Scientific, Hampton, NH, USA).
Histology, immunohistochemistry and analysis
Lung sections (5 mm) were stained with hematoxylin and eosin stain (H&E) or used for immunohistochemistry. Sections were stained with antibodies against PCNA (Invitrogen Corporation, Carlsbad, CA, USA) or active caspase-3 (Abcam Inc., Cambridge, MA, USA). For proliferation analysis, animals received an i.p. injection of 100 ml BrdU (20 mg/ml, ACROS Chemical Co., Pittsburgh, PA, USA) 2 h before sacrifice. Lung sections were stained with rat anti-BrdU antibody (1:400; Accurate Chemical Co., Westbury, NY, USA). Proliferation indices were calculated by counting the number of BrdUpositive nuclei per total nuclei in tumors.
Real-time PCR
Total RNA was isolated from lung tissue using the RNeasy Mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's specifications. DNase-treated samples were subjected to quantitative RT-PCR using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). PCR primers used were the following: CCL17 forward 5 0 -TGCTTCTGG GGACTTTTCTG-3 0 , reverse 5 0 -CATCCCTGGAACACTCC ACT-3 0 ; CCL20 forward 5 0 -TTTTGGGAT G GAATTGGAC AC-3 0 , reverse 5 0 -TGCAGGTGAAGCCTTCAACC-3 0 ; CCL 22 forward 5 0 -GGCACCTATCCAGTGCCACA-3 0 , reverse 5 0 -TGGTGGACCAGCCTGAAACTC-3 0 ; GAPDH (glyceraldehyde 3-phosphate dehydrogenase) forward 5 0 -TGAGGACC AGGTTGTCTCCT-3 0 , reverse 5 0 -CCCTGTTGCTGTAGC CGTAT-3 0 . The relative mRNA expression in each sample was normalized to GAPDH and presented using the comparative Ct method (2 DCt ).
Western blot analysis
Protein extracts from tissue homogenates (100 mg) were separated on a polyacrylamide gel and transblotted for detection of FLAG-cIKKb. Proteins were separated on a 10% acrylamide gel and anti-FLAG antibodies (anti-FLAG conjugated with HRP (horseradish peroxidase) M 2 monoclonal antibody, Sigma-Aldrich, St Louis, MO, USA) were used . Antibodies to p42/p44 MAP kinase (Cell Signaling Technology, Danvers, MA, USA) were used as a loading control. HRP was detected by chemoluminescence using Lumi-Light PLUS western blotting substrate (Roche Diagnostics, Indianapolis, IN, USA).
Mixed lymphocyte reaction (MLR)
An allogeneic MLR protocol were adapted from Banerjee and colleagues (Banerjee et al., 2006) using CD4 þ CD25-effector T cells from spleens of naive FVB mice (1 Â 10 5 per well) as responders, and allogeneic mature bone marrow-derived DCs from C57BL/6 mice as stimulators. DCs were obtained by culturing bone marrow cells in DMEM (Gibco, Grand Island, NY, USA), supplemented with 10% FBS (fetal bovine serum), antibiotics, 50 mM 2-ME (mercaptoethanol) (Gibco), recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) (20 ng/ml, Miltenyi Biotech) and IL-4 (20 ng/ml, Miltenyi Biotech, Auburn, CA, USA), and matured by incubation for 24 h with E. Coli lipopolysacharide (LPS) (1 mg/ml) added on day 7. The ratio between the DCs and CD4 þ CD25-Teff cells was 1:10. To assess T cell proliferation, freshly isolated Teff cells were labeled with CFSE (5 mM; Invitrogen). The suppressive function of CD4 þ CD25 þ T cells (Tregs) was tested on the proliferation of CFSE-labeled Teff cells. The ratio of Teff to Treg cells varied between 1:1 and 1:32. CD4 þ CD25 þ Tregs from lungs of IKTA mice treated for 1 week with 0.5 g/l dox were isolated using a Tregs isolation kit (Miltenyi Biotec). The proliferation of viable CFSE-labeled Teff cells was assessed by flow cytometry. Dead cells were excluded from analysis on the basis of staining with DAPI (4 0 -6-Diamidino-2-phenylindole, Invitrogen).
Statistics
Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). Pair-wise comparisons were made using Welch's t test. Comparisons among groups were done by one-way analysis of variance using Tukey's post test. Results were presented as mean±s.e. of the mean. P values o0.05 were considered significant.
